Other Long Term Assets - Ryvu Therapeutics SA (WSE:RVU) - Alpha Spread
R

Ryvu Therapeutics SA
WSE:RVU

Watchlist Manager
Ryvu Therapeutics SA
WSE:RVU
Watchlist
Price: 54.1 PLN -1.64% Market Closed
Market Cap: 1.3B PLN
Have any thoughts about
Ryvu Therapeutics SA?
Write Note

Ryvu Therapeutics SA
Other Long-Term Assets

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Ryvu Therapeutics SA
Other Long-Term Assets Peer Comparison

Comparables:
I
IGN
M
MDB
S
SLV

Competitive Other Long-Term Assets Analysis
Latest Figures & CAGR of Competitors

Company Other Long-Term Assets CAGR 3Y CAGR 5Y CAGR 10Y
R
Ryvu Therapeutics SA
WSE:RVU
Other Long-Term Assets
zł5.2m
CAGR 3-Years
110%
CAGR 5-Years
2%
CAGR 10-Years
N/A
I
Inno-Gene SA
WSE:IGN
Other Long-Term Assets
zł72k
CAGR 3-Years
-41%
CAGR 5-Years
-49%
CAGR 10-Years
-36%
M
Medicofarma Biotech SA
WSE:MDB
Other Long-Term Assets
N/A
CAGR 3-Years
N/A
CAGR 5-Years
N/A
CAGR 10-Years
N/A
S
Selvita SA
WSE:SLV
Other Long-Term Assets
zł14.8m
CAGR 3-Years
-8%
CAGR 5-Years
N/A
CAGR 10-Years
N/A

See Also

What is Ryvu Therapeutics SA's Other Long-Term Assets?
Other Long-Term Assets
5.2m PLN

Based on the financial report for Mar 31, 2024, Ryvu Therapeutics SA's Other Long-Term Assets amounts to 5.2m PLN.

What is Ryvu Therapeutics SA's Other Long-Term Assets growth rate?
Other Long-Term Assets CAGR 5Y
2%

Over the last year, the Other Long-Term Assets growth was -51%. The average annual Other Long-Term Assets growth rates for Ryvu Therapeutics SA have been 110% over the past three years , 2% over the past five years .

Back to Top